Literature DB >> 19220018

10-(2-oxo-2-phenylethylidene)-10H-anthracen-9-ones as highly active antimicrotubule agents: synthesis, antiproliferative activity, and inhibition of tubulin polymerization.

Helge Prinz1, Peter Schmidt, Konrad J Böhm, Silke Baasner, Klaus Müller, Eberhard Unger, Matthias Gerlach, Eckhard G Günther.   

Abstract

A series of 10-(2-oxo-2-phenylethylidene)-10H-anthracen-9-ones were synthesized and evaluated for interactions with tubulin and for antiproliferative activity against a panel of human and rodent tumor cell lines. The 4-methoxy analogue 17b was most potent, displaying IC(50) values ranging from 40 to 80 nM, including multidrug resistant phenotypes, and had excellent activity as an inhibitor of tubulin polymerization (IC(50) = 0.52 microM). Concentration-dependent flow cytometric studies showed that KB/HeLa cells treated with 17b were arrested in the G2/M phases of the cell cycle (EC(50) = 90 nM). In competition experiments, 17b strongly displaced [(3)H]-colchicine from its binding site in the tubulin. The results obtained demonstrate that the antiproliferative activity is related to the inhibition of tubulin polymerization.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19220018     DOI: 10.1021/jm801338r

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  2 in total

1.  Direct modulation of microtubule stability contributes to anthracene general anesthesia.

Authors:  Daniel J Emerson; Brian P Weiser; John Psonis; Zhengzheng Liao; Olena Taratula; Ashley Fiamengo; Xiaozhao Wang; Keizo Sugasawa; Amos B Smith; Roderic G Eckenhoff; Ivan J Dmochowski
Journal:  J Am Chem Soc       Date:  2013-03-29       Impact factor: 15.419

2.  Target Based Designing of Anthracenone Derivatives as Tubulin Polymerization Inhibiting Agents: 3D QSAR and Docking Approach.

Authors:  Abdul Samad; Moawiah M Naffaa; Mohammed Afroz Bakht; Manav Malhotra; Majid A Ganaie
Journal:  Int J Med Chem       Date:  2014-04-17
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.